Fagan Associates, Inc. Pfizer Inc Transaction History

Fagan Associates, Inc.

$556 Million
Q2 2024

A detailed history of Fagan Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Fagan Associates, Inc. holds 7,460 shares of PFE stock, worth $221,935. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,460

Holding current value

$221,935

% of portfolio

0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $188,439 - $220,816	7,460 New	7,460 $208,000
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $46,637 - $60,715	-1,184 Reduced 1.9%	61,209 $2.5 Million
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $2.15 Million - $2.8 Million	51,397 Added 467.42%	62,393 $0
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $43 - $53	1 Added 0.01%	10,996 $481,000
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $9,399 - $11,144	202 Added 1.87%	10,995 $576,000
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $27,358 - $33,900	-598 Reduced 5.25%	10,793 $559,000
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $66,359 - $98,367	1,606 Added 16.41%	11,391 $673,000
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $51,849 - $66,604	1,321 Added 15.61%	9,785 $421,000
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $38,962 - $44,137	1,085 Added 14.7%	8,464 $331,000
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $32,652 - $36,825	975 Added 15.22%	7,379 $267,000
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $214,341 - $272,554	6,404 New	6,404 $236,000
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $157,611 - $225,193	-5,831 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $4,115 - $4,670	-125 Reduced 2.1%	5,831 $228,000
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $3,249 - $4,213	-100 Reduced 1.65%	5,956 $214,000
Q2 2019 Jul 12, 2019	BUY	$36.98 - $41.52 $32,727 - $36,745	885 Added 17.11%	6,056 $262,000
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $3,750 - $4,120	100 Added 1.97%	5,171 $220,000
Q4 2018 Feb 05, 2019	BUY	$38.47 - $43.86 $1,154 - $1,315	30 Added 0.6%	5,071 $221,000
Q3 2018 Nov 06, 2018	BUY	$34.47 - $41.81 $173,763 - $210,764	5,041 New	5,041 $222,000
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $1.17 Million - $1.36 Million	-36,813 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $12,040 - $12,774	362 Added 0.99%	36,813 $1.33 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $104,253 - $114,846	3,363 Added 10.16%	36,451 $1.3 Million
Q2 2017 Aug 07, 2017	BUY	N/A	33,088	33,088 $1.11 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.54 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.95 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.49 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fagan Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fagan Associates, Inc. with notifications on news.

Account

Fagan Associates, Inc. Pfizer Inc Transaction History